对于逆转罗库诱导的深度神经肌肉阻塞,阿达姆加马德克斯的有效性和安全性:一个多中心,随机的IIb期研究
Yanhua Zhao1, Sifan Chen1, Wenqin Xie2
1Department of Anesthesiology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Clinical and translational science
|January 24, 2024
概括
亚当甘马德克斯有效和安全地逆转由罗库诱导的深度神经肌肉阻塞 (NMB),为苏甘马德克斯提供了一个有希望的替代品. 这项研究发现,阿达姆加马德克斯和苏加马德克斯之间的疗效相似,阿达姆加马德克斯表现出良好的耐受性和低的不良事件.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 神经肌肉阻塞 (NMB) 的快速逆转在麻醉中至关重要,但仍然是一个挑战.
- 苏加马德克斯是一种广泛使用的逆转剂,但正在寻找替代品.
研究的目的:
- 为了评估 adamgammadex 与 sugammadex 相比的有效性和安全性,以扭转深层罗库诱导的 NMB.
- 评估不同剂量的adamgammadex的逆转时间,成功率和安全性概况.
主要方法:
- 一项多中心,随机的IIb期研究,涉及80名接受手术的患者 (18-64岁,ASA等级1-2).
- 患者接受了阿达姆加马德克斯 (7,8或9毫克/公斤) 或苏加马德克斯 (4毫克/公斤).
- 主要终点:时间到四列车比率 (TOFr) 恢复到0.9.
主要成果:
- 在阿达姆加马德克斯 (7,8,9毫克/公斤) 和苏加马德克斯 (4毫克/公斤) 组之间没有观察到有效性的显著差异.
- 亚当麦德克斯9毫克/公斤在2.9分钟的几何平均值中实现了逆转.
- 与sugammadex相比,adamgammadex表现出良好的耐受性和与药物相关的不良事件的低发病率.
结论:
- 亚当甘马德克斯 (Adamgammadex) 有助于快速逆转深层罗库诱导的NMB.
- 亚当麦德克斯 (Adamgammadex) 具有良好的耐受性和低不良事件率,具有良好的安全性.
- 亚当甘马德克斯 (Adamgammadex) 是一种潜在的,有前途的替代品,用于治疗NMB逆转的sugammadex.
相关概念视频
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
422
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
422
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.8K
Skeletal Muscle Relaxants: Adverse Effects
373
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
373
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
454
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
454
Depolarizing Blockers: Mechanism of Action
1.6K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.6K


